[Form 4] Willdan Group, Inc. Insider Trading Activity
Willdan Group, Inc. director Thomas D. Brisbin reported multiple open-market sales of common stock on 08/21/2025 totaling 125,000 shares. Sales occurred in several tranches at weighted average prices ranging from $101.87 to $106.34, reducing his beneficial ownership to 188,291 shares. The remaining stake includes restricted stock grants that vest in 2026 totaling 8,739 shares across three grant dates. Transactions were reported by an attorney-in-fact and the filer offers to provide detailed per-price breakdowns on request.
- Transparency: Form 4 includes weighted-average price footnotes and offers to provide per-price sale details on request
- Ongoing alignment: Reporting person retains 188,291 shares and 8,739 restricted shares that vest in 2026, maintaining continued exposure to company performance
- Proper execution: Filing executed by an attorney-in-fact and appears to meet Form 4 disclosure requirements
- Significant insider selling: Reporting person sold a total of 125,000 shares on 08/21/2025, which is a sizable disposition by a director
- Concentration of trades: Multiple large sales occurred on a single date, which may reduce insider shareholding substantially in a short period
Insights
TL;DR Director sold a sizable block of shares—125,000—reducing ownership but retains a meaningful position with restricted shares pending vesting.
The scale of the disposals equals a clear liquidity event by the insider rather than routine small trades. Sales spanned a narrow $101–$106 price band, indicating execution across multiple prices within a single day. Remaining direct ownership of 188,291 shares still represents a material stake in the company; the presence of ~8,739 restricted shares vesting in 2026 preserves future alignment with shareholders.
TL;DR Substantial insider sales were disclosed; reporting appears compliant and includes vesting details and offer to provide granular pricing.
The Form 4 discloses multiple sales executed the same date and provides weighted-average price footnotes and vesting schedules for restricted stock, which supports regulatory transparency. Filing was signed by an attorney-in-fact. From a governance perspective, the disclosure meets Form 4 content requirements; no additional governance issues or exemptions are evident in the filing.